Mirum Pharmaceuticals (MIRM) Net Equity Issued and Repurchased (2020 - 2023)

Mirum Pharmaceuticals' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $14.5 million for Q1 2023.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $14.5 million in Q1 2023; TTM through Dec 2023 was $14.5 million, a N/A change from a year earlier, with the FY2023 full-year figure at $14.5 million, down 31.98% from the prior year.
• Net Equity Issued and Repurchased declined to $14.5 million in Q1 2023 per MIRM's latest filing, from $27.6 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $70.0 million in Q4 2020 and bottomed at $2.2 million in Q3 2020.
• The 3-year median for Net Equity Issued and Repurchased is $27.6 million (2022), against an average of $31.1 million.